AbbVie Reports Encouraging Data on HCV Drug

11 Dec

Bystocknews ABBV, stock Comments Off

[Zacks] – AbbVie released positive results from a phase III study evaluating 3D regimen. more

View todays social media effects on ABBV

View the latest stocks trending across Twitter. Click to view dashboard